 |
Ohio Administrative Code (Last Updated: January 12, 2021) |
 |
3701 Department of Health - Administration and Director |
|
Chapter3701-83. Licensing Provisions for Health Care Facilities |
3701-83-23.4. Infection control and prevention - freestanding dialysis centers
-
(A) In addition to the requirements established in rules 3701-83-09 and 3701-83-23.1 of the Administrative Code, each dialysis center shall develop and follow written policies and procedures for preventing and controlling infections. The policies and procedures shall include, but are not limited to, the following:
(1) The aseptic and isolation techniques to be used;
(2) Use of the isolation room or dedicated station or area, where applicable;
(3) Handling and disposal of biohazardous and potentially infectious waste;
(4) Cleaning and maintenance of equipment;
(5) Cleaning and disinfection of surfaces; and
(6) Use of standard precautions and personal protective equipment.
(B) Each dialysis center shall establish and follow a preventive maintenance program that includes periodic calibration, cleaning and adjustment of all equipment in accordance with manufacturer's instructions.
(C) In addition to the water requirements established in rule 3701-83-23.1 of the Administrative Code, each dialysis center shall:
(1) Culture and conduct water specimen analysis used for dialysis purposes at least every thirty days for bacteria;
(2) Analyze water used for dialysis purposes at least every one hundred and eighty days for chemicals;
(3) Treat water as necessary to maintain a continuous water supply that is biologically and chemically compatible with acceptable dialysis techniques.
(D) Each dialysis center shall conduct routine surveillance of patients and staff for hepatitis B using the most sensitive test methods available.
(1) Each patient must be screened for hepatitis B surface antigen (HBsAG) and hepatitis B surface antibody before admission to the dialysis facility in order to determine their serologic status for surveillance purposes;
(2) New employees must be screened for hepatitis B surface antigen (HBsAG) and hepatitis B surface antibody before or at the time of hire in order to determine their serologic status for surveillance purposes; and
(3) Each dialysis center shall offer the hepatitis B vaccine to all susceptible patients and all staff and document such action in the patient's medical record or the staff member's personnel record.
(E) Each dialysis facility shall investigate and report to the director incidents of infections associated with the provision of dialysis services. Efforts shall be made to determine the origin of any such infection and remedial action shall be taken to protect all non-infected patients and prevent recurrence.
(F) Each dialysis facility shall comply with the reporting requirements established by rule 3701-3-03 and paragraph (A)(10) of rule 3701-83-23.1 of the Administrative Code.